Gain-or loss-of-function mutations in fibroblast growth factor receptor 3 (FGFR3) result in cranial vault defects -highlighting the protein's role in membranous ossification. Zebrafish express high levels of fgfr3 during skull development; in order to study FGFR3's role in cranial vault development, we generated the first fgfr3 lossof-function zebrafish (fgfr3 lof/lof ). The mutant fish exhibited major changes in the craniofacial skeleton, with a lack of sutures, abnormal frontal and parietal bones, and the presence of ectopic bones. Integrated analyses (in vivo imaging, and single-cell RNA sequencing of the osteoblast lineage) of zebrafish fgfr3 lof/lof revealed a delay in osteoblast expansion and differentiation, together with changes in the extracellular matrix. These findings demonstrate that fgfr3 is a positive regulator of osteogenesis.
Introduction
Cranial vault anomalies occur in many fibroblast growth factor receptor (FGFR)related disorders. The progressive development of the cranial vault is initiated during embryogenesis, and is completed during adulthood by intramembranous ossification (except for the supra-occipital bones). Cranial vault formation starts with the condensation of mesenchymal cells, which then differentiate into the osteoprogenitors and osteoblasts required for bone matrix synthesis. The frontal and parietal bones develop from ossification centers formed by the deposition of non-mineralized bone matrix. At the edge of developing bones, new osteoblasts continually differentiate and thus expand the ossification centers. When two bones meet, a suture composed of mesenchymal tissue forms between two membranous zones.
The genes coding for members of the FGFR family are known to be involved in cranial vault formation. Along with the fibroblast growth factor (FGF) ligands, the FGFRs are expressed extensively in both developing and mature bones, where they regulate osteogenesis. Dysregulation of FGFRs is often associated with premature suture fusion; in the skull, this leads to craniofacial anomalies referred to as craniosynostoses (Wilkie et al., 2017) . The p.Pro250Arg and p.Ala391Glu gain of function mutations in FGFR3 respectively cause Muenke syndrome (the most common craniosynostosis) and Crouzon syndrome with acanthosis nigricansboth of which are characterized by premature suture fusion in the skull vault (Meyers et al., 1995; Muenke et al., 1997) . In earlier research, we observed a defect in membranous ossification (revealed by the presence of a large fontanelle) in achondroplasia (the most common form of dwarfism, due to a p.Gly380Arg FGFR3 gain-of-function mutation), (Di Rocco et al., 2014) .
Similarly, the absence of FGFR3 also affects skull formation, as demonstrated by the presence of microcephaly and Wormian bones in people with camptodactyly-tall stature-scoliosis-hearing loss syndrome (CATSHL) (Makrythanasis et al., 2014; Toydemir et al., 2006) .
We previously described the partial, premature fusion of coronal sutures and impaired frontal bone formation in an (Fgfr3 Y367C/+ ) murine model mimicking achondroplasia; this provided clear evidence that FGFR3 signaling is important for membranous ossification (Di Rocco et al., 2014) . Surprisingly, the murine model of Muenke syndrome (Fgfr3 P244R/+ ) rarely displays premature fusion of the coronal 3 sutures, and the skull deformities are very mild (Twigg et al 2009) . The Fgfr3 knockout mouse model does not have an obvious skull vault phenotype (Deng et al., 1996; Valverde-Franco et al., 2004) . Hence, FGFR3's specific role in skull vault formation has yet not been determined. In the zebrafish, Fgfr3 is highly conserved, and is expressed in mature osteoblasts within the osteogenic fronts and along the frontal bone (Topczewska et al 2016 , Ledwon 2018 . The late development and accessibility of the cranial vault in the juvenile zebrafish provides a unique opportunity to study each of the steps in osteogenesis during skull bone formation (Cornille et al., 2019; Topczewska et al., 2016) . In the present report, we describe strong skull vault anomalies in an Fgfr3 loss-of-function mutant zebrafish model (fgfr3 lof/lof ) with abnormal frontal and parietal bones, the presence of ectopic bones, and a lack of suture formation. After we had used the transgenic fluorescent line Tg(sp7:mCherry; bglap:GFP) to label immature and mature osteoblasts, the sequential imaging of live zebrafish throughout their development showed that the differentiation and expansion of immature osteoblast were impaired in fgfr3 lof/lof fish. Lastly, we used single-cell RNA sequencing to assess the impact of fgfr3 loss of function on fish cranial vaults at 9 mm standard length (SL). We confirmed the presence of a defect in immature osteoblast differentiation, and observed marked differences in the expression of extracellular matrix (ECM) components. We hypothesized that in the absence of Fgfr3, defects in the ECM would affect cell-cell communication and the recruitment of new osteoblasts during bone growth. We conclude that Fgfr3 is a positive regulator of osteogenesis during cranial vault formation.
Results

Inhibition of Fgfr3's tyrosine kinase activity affects cranial vault development in zebrafish
The zebrafish fgfr3 gene is strongly transcribed in osteoblasts during cranial vault formation (Ledwon et al., 2018) . The alignment of the deduced amino acid sequence of zebrafish Fgfr3 with that of its human homolog (FGFR3) shows a high level of homology between the two proteins (77% overall, and more than 90% when considering the tyrosine kinase domain alone; Figure 1 -supplement 1). In order to investigate Fgfr3's role, we used the tyrosine kinase inhibitor BGJ398 (infigratinib, LC Laboratories) to block the factor's tyrosine kinase activity during cranial vault development (Gudernova et al., 2016; Komla-Ebri et al., 2016) . Zebrafish larvae with a standard length (SL) of 7 mm (7SL) and expressing mCherry in osteoblasts (Tg(sp7: mCherry) were injected with BGJ398 every other day for 15 days ( Figure 1A ). After treatment, BGJ398-treated larvae had the same SL as the larvae treated with vehicle (3% DMSO), confirming that BGJ398 did not interfere with overall growth ( Figure 1B) .
We found that the mean ± SD surface area of the fontanelle (i.e. the osteoblast-free area of the cranial vault) was significantly larger in BGJ398-treated larvae (347791 ± 50768 µm²) than in DMSO-treated larvae (135171 ± 22043 µm²; p=0.014) ( Figure 1C ).
Our results indicate that in the zebrafish, the inhibition of Fgfr3 activity strongly disrupts osteoblast invasion during cranial vault development.
fgfr3 loss of function induces craniofacial and axial skeleton anomalies in three-
month-old zebrafish
We next used CrispR/Cas9 technology to generate two different loss-of-function fgfr3 zebrafish lines, with a stop codon at position 377 for fgfr3 lof1/lof1 (Figure 2A ) and at position 278 for fgfr3 lof2/lof2 (Figure 2 supplement 1). The predicted sequence indicated that both mutations led to the formation of a truncated protein lacking both the transmembrane domain and the tyrosine kinase domain. Since the two mutations produced identical phenotypes, we conducted all subsequent experiments with fgfr3 lof1/lof1 line. A quantitative real-time PCR (qPCR) analysis confirmed that fgfr3 expression was abnormally low in fgfr3 lof1/lof1 zebrafish, whereas the expression of fgfr1a, fgfr1b and fgfr2 was not affected ( Figure 2B ).
Three-month-old fgfr3 lof1/lof1 fish displayed major craniofacial defects, with a flat face and microcephaly ( Figure 2C ). X-ray analyses confirmed that fgfr3 lof1/lof1 had an abnormal skull shape and that the cranial vault was less mineralized than in fgfr3 +/+ fish ( Figure 2D , E). Moreover, fgfr3 lof1/lof1 fish were shorter than their control siblings (1.85 ± 0.06 cm vs. 2.07 ± 0.06 cm, respectively; p=0.035) ( Figure 2F ). fgfr3 lof1/lof1 fish also displayed a more strongly curved spine than controls, as measured by the angle formed between the base of the skull and the Weberian apparatus (fgfr3 +/+ :109.7 ± 2.0°; fgfr3 lof1/lof1 : 84.5 ± 3.5°; p<0.0001) ( Figure 2D ,G). fgfr3 lof1/lof1 fish also had shorter precaudal and caudal vertebrae than fgfr3 +/+ fish, although the intervertebral spacing Lastly, we noticed that the swim bladder of fgfr3 lof1/lof1 was formed by a single chamber; this contrasted with the anterior chamber and posterior chamber that comprise the wild-type swim bladder ( Figure 2C ). These results indicate that the absence of Fgfr3 prevents evagination from the cranial end of the swim bladder's original sac (Robertson et al., 2007) .
The low SL, flat face, microcephaly, cranial vault hypomineralization and swim bladder defects were also observed in fgfr3 lof2/lof2 fish -confirming that these phenotypes are directly correlated with fgfr3 loss-of-function mutations (Figure 2 supplement 2). Taken as a whole, our findings indicate that Fgfr3 has a role in development of the craniofacial and axial skeletons in zebrafish.
fgfr3 loss of function induces severe frontal and parietal bone defects, together with Wormian bone formation
To better characterize the craniofacial defects in fgfr3 lof1/lof1 , we used Alizarin red S staining and micro computed tomography (µCT) to study three-month-old fish.
The µCT analyses confirmed that fgfr3 lof1/lof1 fish had a microcephalic skull, with low skull height and length ( Figure 3A , B) and a normal skull width (Figure 3D-F). We observed that the foramen of the cranial vault was larger in fgfr3 mutants than in control siblings. The mean ± SD surface area of the fontanelle (located between the frontal and parietal bones) was 0.0226 ± 0.0091 mm² in fgfr3 +/+ fish and 0.988 ± 0.186 mm² in fgfr3 lof1/lof1 fish (p=0.0009; (Figure 3G -I). The abnormally large fontanelle in fgfr3 lof1/lof1 fish was associated with significantly smaller frontal bones (relative decrease: 42%) and parietal bones (relative decrease: 46%). The mean ± SD thickness of the parietal bone was not affected (fgfr3 +/+ :13.8 ± 0.7 µm; fgfr3 lof1/lof1 : 12.5 ± 1.4 µm; p=0.4251).
Interestingly, we noted the presence of ectopic bones between the frontal and parietal bones in fgfr3 lof1/lof1 fish ( Figure 3B , C). The ectopic bones resembled the Wormian bones described in patients carrying a homozygous FGFR3 loss-of-function mutation (Makrythanasis et al., 2014) . To study changes in the cranial vault phenotype during growth, we analyzed 6-month-old fish (Figure 3 With regard to the viscerocranium, we did not observe any obvious abnormalities in the Meckel cartilage of fgfr3 lof1/lof1 mutants ( Figure 3 , Table 1 ).
Macroscopic analyses of fgfr3 lof1/lof1 larvae on days 5 and 9 post-fertilization (dpf) did not reveal any developmental defects; there were no significant head abnormalities or delays in branchial arch ossification ( Figure 3 Delayed parietal and frontal bone formation in fgfr3 lof1/lof1 fish was evidenced by the presence of large fontanelles. The ectopic bone formation described above appeared to compensate for this delay. The absence of viscerocranial anomalies suggests that the difference in skull shape was mainly due to bone abnormalities in the cranial vault.
Osteoblast expansion and differentiation are affected in fgfr3 lof1/lof1 fish
We next used Alizarin red S staining to study the tissues that are mineralized during craniofacial skeleton formation from 8SL to 11SL ( Figure 4A ). From 9SL onwards, Alizarin red S staining of the neurocranium and the dermatocranium was slightly less intense in fgfr3 lof1/lof1 fish than in fgfr3 +/+ fish. This phenotype developed progressively, as highlighted by our observations of 11SL fish. To assess the bone formation process in the cranial vault, we performed Alizarin red S in vivo labeling at 9SL and then calcein labeling 7 days later ( Figure 4B ). There were significantly less newly formed bones in fgfr3 lof1/lof1 fish (6 ±0.2 µm/day) than in fgfr3 +/+ fish (26 ± 1.2 µm/day; p<0.0001) ( Figure 4C ). These results showed that Fgfr3 loss of function impaired the formation of cranial vault bones and had much the same effect as BGJ398 treatment ( Figure 1A , 1C).
Given that bones are formed by the action of osteoblasts, we decided to study these cells during cranial vault formation. We used Tg(Sp7:mCherry; bglap:GFP); fgfr3 +/+ /fgfr3 lof1/lof1 fish to express mCherry and GFP in immature and mature osteoblasts, respectively, with weekly sequential imaging of the fish from 7 (SL) to 11SL ( Figure 5A ). The ossification centers of the parietal and frontal bones were present at 7SL in fgfr3 +/+ fish (as revealed by the presence of immature osteoblasts) and expanded at later stages of development ( Figure 5A ). At 11SL, the immature osteoblasts of the frontal and parietal bones overlapped and formed coronal sutures.
Mature osteoblasts were present in frontal bones at 7SL and in parietal bones at 8SL. At 9SL and 11SL, mature osteoblasts almost entirely covered the frontal and parietal bones; only a thin band of immature osteoblasts remained at the edges.
Interestingly, we found that immature osteoblasts were present in both fgfr3 lof1/lof1 and control fish at 7SL; however, the mutant's frontal bones seemed to be fragmented ( Figure 5A ). From 8SL onwards, there were smaller ossification centers in fgfr3 lof1/lof1 fish than in controls ( Figure 5A , 5B); this difference was accentuated between 9SL and 11SL and was associated with an irregular bone formation front. Quantitative analyses of fgfr3 lof1/lof1 and fgfr3 +/+ parietal bones at 9SL and 11SL showed that as expected, a low parietal volume was correlated with a low immature osteoblast (mCherry + ) count ( Figure 5B , 5C). Comparisons of immature osteoblast counts on parietal bones from 9SL to 11SL revealed an impairment in cell expansion in fgfr3 lof1/lof1 fish; the number of immature osteoblasts increased by 149% in wild-type fish but only by 74% in fgfr3 lof1/lof1 fish ( Figure 5E ). Moreover, the defective expansion of immature osteoblasts was associated with a low mature osteoblast count at 9SL and 11SL ( Figure 5A , 5D). The mature osteoblast count increased by 122% from 9SL to 11SL in wild-type fish but only by 32% in the mutant. This was consistent with the huge surface area covered with only immature osteoblasts at the bone formation front at 11SL ( Figure 5A, 5E) . The presence of a maturation defect was confirmed by the abnormally low number of GFPpositive cells per µm 3 at 11SL in fgfr3 lof1/lof1 fish, relative to fgfr3 +/+ fish ( Figure 5F ).
These findings demonstrated that the osteoblast maturation is dramatically impaired in fgfr3 lof1/lof1 zebrafish.
We next used EdU incorporation and anti-pH3 immunolabeling to study the proliferation of immature osteoblasts ( Figure 5G ) at 9SL. Most of the EdU + mCherry + cells in parietal bones were present at the edges of the ossification centers in both controls and mutants. However, we observed a significantly greater number of EdU + mCherry + cells in fgfr3 lof1/lof1 fish ( Figure 5H ). Following up on these findings, we observed that the mCherry + cell count in G2/M (using an anti-pH3 antibody) was similar in mutants and controls ( Figure 5I ). Hence, the absence of Fgfr3 appeared to lead to dysregulation of the immature osteoblast cell cycle, with a longer S phase in mutants than in controls. This relative increase in the cell cycle duration was consistent with the delay in the immature osteoblast expansion observed between 9SL and 11SL in the mutant. Lastly, we investigated the apoptosis of the immature osteoblasts; TUNEL analyses revealed that the impaired bone formation was not due to premature death of the immature osteoblasts ( Figure 5J ).
In conclusion, our results demonstrate that Fgfr3 is a positive regulator of immature osteoblast expansion and differentiation during cranial vault formation. Nevertheless, the major delay in ossification center formation could not be explained by the observed changes of their cell cycle alone. Our findings indicated that the absence of Fgfr3 also affected the recruitment of newly immature osteoblasts formed from osteoprogenitors.
Identification of osteogenic cell subpopulations involved in cranial vault formation with single-cell RNA sequencing
In order to better characterize the cellular impact of fgfr3 loss of function, we performed a single-cell RNA sequencing on fgfr3 lof1/lof1 and fgfr3 +/+ cranial vaults at 9 9SL. We used the Chromium system (10x Genomics) to profile the transcriptome of nearly 28000 single cells isolated from cranial vaults from two fgfr3 lof1/lof1 fish and two fgfr3 +/+ fish ( Figure 6A ). After excluding outlier cells and genes, 19245 cells and an average of 1233 genes per cells were included in our analysis ( Figure 6 -data 1). By applying the Seurat pipeline (Stuart et al., 2019) , we identified 20 major cell clusters Figure 6E ). We confirmed the presence of a large number of osteoprogenitors in the zebrafish skull at 9SL. Based on strong expression of the mesenchymal markers paired related homeobox 1a (encoded by prrx1a), muscle segment homeobox 1b (msx1b) and muscle segment homeobox 3 (msx3), cluster 9 was the only cluster that contained a large number of precursor osteoprogenitor cells (OP0). The abundance of cell cycle regulators and proliferative markers in cluster 12 (Figure 6 -data 2) indicated that the latter cluster contained proliferative osteoprogenitors (OP2). Transcriptomic profiles of cluster 0 (OP3) and 3 (OP4) indicated that they both contained intermediate osteoprogenitor cells. Next, we studied the mRNA expression of col1a1 (coding for collagen type 1a1), cdh11
(cadherin-11) and sparc (osteonectin) -all of which are known to be upregulated during osteogenesis (Kii et al., 2004; Komori, 2019) . We concluded that cluster 1 (OP5) contained late osteoprogenitors ( Figure 6E ). The increase in the expression of these genes from OP0 to OP5 reflected the progressive differentiation of osteoprogenitor cells. Osteoblasts were found in cluster 4, where we observed the expression of osteoblastic markers such as osterix (sp7), osteopontin (spp1) and osteocalcin (bglap).
We were not able to classify cluster 13 (OP1).
To validate our classification of OP and OB clusters, we performed Monocle2 pseudotime trajectory analyses on fgfr3 +/+ cells (Trapnell et al., 2014) . As shown in Figure 6G , OP and OB cells presented a relatively linear developmental progression, with few branches. The OP0 and OB clusters dominated the two ends of the progression trajectory; OB corresponded to the least mature branch in pseudotime ( Figure 6 ). The OP5 cluster appeared to contain mostly late osteoprogenitor cells, and OP4 and OP3 contain mostly intermediate progenitors. It appeared that the cells comprising OP4 were in a less differentiated state than the cells comprising OP3. As expected, the cells forming the OP2 cluster (corresponding to proliferative osteoprogenitors) were outside the differentiation process. Interestingly, we noted that OP1 and OP0 were located at the beginning of pseudotime -indicating that OP1 could be formed also by precursor cells. We found that the four samples contributed to all the CH, OP and OB clusters, and that there was no significant difference was observed between the genotypes ( Figure 6 -supplement 1H). These results proved that absence of Fgfr3 did not affect the osteoprogenitor cell count at 9SL and confirmed our OP and OB clusters classification.
The OB cells encompassed both immature and mature osteoblasts. In order to discriminate between these two stages, we performed a new principal component analysis (PCA) and a uniform manifold approximation and projection (UMAP) analysis on cluster 4 (OB). This enabled us to identify 3 new subclusters; based on the expression of twist1a, sp7, col1a1, col10a1a and bglap, we assigned the OB1, OB2
and OB3 clusters to preosteoblasts, immature osteoblasts and mature osteoblasts, respectively (Figure 6 H,I). We noted that the proportion of mature osteoblasts (OB3) in the cranial vault was lower in fgfr3 lof1/lof1 fish than in fgfr3 +/+ fish ( Figure 6 supplemental 1 I and J). These results were consistent with the sequential live imaging 11 data showing fewer mature osteoblasts in the cranial vault for fgfr3 lof1/lof1 than for fgfr3 +/+ at 9SL ( Figure 5 ).
FGFR3 is expressed by late osteoprogenitors through to mature osteoblasts
In the wild type, fgfr3 appeared to the fgfr gene most strongly expressed by osteoblasts and chondrogenic cells ( Figure 7A -C); this observation was in line with the literature data (Ledwon et al., 2018; Topczewska et al., 2016) . fgfr3 was expressed in 40% of the OP5 late osteoprogenitors and in 75% of the osteoblasts. The highest expression was observed in mature osteoblasts. These data confirm the crucial role of fgfr3 in osteoblast maturation and indicate that fgfr3 might be also associated with earlier steps in osteogenesis. With regard to the other fgfr receptors, the expression of the isoform fgfr1a was upregulated during osteoprogenitor differentiation but fgfr1b was almost absent ( Figure 7A ). fgfr2 was expressed weaklier than fgfr3 during osteogenesis; as expected, it was most strongly expressed in OC0 precursor cells ( Figure 7A ). We noted high expression levels of fgfr4 (whose specific role in osteogenesis is still unknown) in 47% of osteoblasts ( Figure 7B ). We also noted that fgf18a and b (specific ligands of fgfr3) are the most strongly expressed fgfr genes during cranial bone development (data not shown). Apart from the downregulation of fgfr3, no significant differences in the expression of three other fgfr genes were observed in fgfr3 lof1/lof1 cells (vs. the wild type). These data confirmed that fgfr3 had indeed been knocked down in fgfr3 lof1/lof1 zebrafish, and showed that the other fgfr genes could not compensate for the absence of fgfr3 via a putative rescue mechanism.
Fgfr3 is a positive regulator of osteoprogenitor and osteoblast differentiation
To identify changes in gene expression induced by fgfr3 loss of function in late osteoprogenitors (OP5) and osteoblasts (OB), we performed in OP5 and OB clusters differential gene expression analysis between fgfr3 +/+ and fgfr3 lof1/lof1 in OP5 and OB clusters. To refine our list of differentially expressed genes (DEGs), we cross-checked the results obtained from each pair-wise comparison (i.e. 1-fgfr3 +/+ vs. 1-fgfr3 lof1/lof1 ; 1-
DEGs are listed in Figure 8 data 1.
As expected, we noted marked downregulation of the mature osteoblast marker bglap in fgfr3 lof1/lof1 cells; this confirmed the impairment in osteoblast differentiation ( Figure 5 ) (Hauschka et al., 1989) . The defective differentiation of both osteoblasts and late osteoprogenitors was supported by the dysregulation of other genes. In fgfr3 lof1/lof1 osteoblasts, we observed the downregulation of sat1a.2, coding for the spermidine/spermine N1-acetyltransferase 1a, duplicate 2 -a catabolic regulator of polyamine ( Figure 8A ). Polyamines and Ssat (the mouse ortholog of sat1a.2) are reportedly positive regulators of osteogenesis (Lee et al., 2013; Pirnes-Karhu et al., 2015) . In fgfr3 lof1/lof1 late osteoprogenitors, we noted the downregulation of inhibitor of differentiation 2 (id2b) coding for one of the Id proteins that promote osteoprogenitor proliferation and inhibit terminal differentiation (Peng et al., 2004) . hsp90aa1.2, hsp70.1, and hsp70l hsp70.2 expressions are also downregulated in fgfr3 lof1/lof1 late osteoprogenitors ( Figure 8B ). Several previous studies have shown that the mammalian orthologues hsp70 and hsp90 are positive regulators of osteoblast migration and differentiation (Kawabata et al., 2018; Zhang et al., 2018) .
The downregulation of all these genes was in line with the defective osteoblast differentiation observed in our mutants, and highlights fgfr3 as a positive regulator of osteoblast and osteoprogenitor differentiation.
A lack of FGR3 affects the mineralization process and the ECM
In both late osteoprogenitors and osteoblasts, we noted that fgfr3 loss of function impacted the expression of a large number of genes involved in mineralization and in ECM formationboth of which are fundamental for bone formation. We observed the upregulation of phosphoethanolamine/phosphocholine phosphatase 1 (phospho1, coding for an enzyme that helps to initiate matrix mineralization) in fgfr3 lof1/lof1 osteoblasts ( Figure 8B) (Roberts et al., 2007) . In fgfr3 lof1/lof1 late osteoprogenitors, we observed the downregulation of asporin (aspn). This small leucine-rich repeat proteoglycan/protein is expressed by osteoblast progenitor cells and promotes collagen mineralization (Kalamajski et al., 2009) (Figure 8B ). phex is also involved in the mineralization process (Miao et al., 2001) , and was downregulated in the fgfr3 lof1/lof1 OP5 cluster. Concerning the ECM, most of the genes were found in OP5. Indeed, we observed the upregulation of several genes coding for collagen proteins (col2a1b, 13 col12a1b, col12a1a and col6a1) ( Figure 8B ). We also noted the upregulation of fibromodulin (zgc:113307;fmod), a collagen-binding small leucine-rich proteoglycan regulating collagen fibril formation in the fgfr3 lof1/lof1 OP5 population ( Figure 8B) . We observed the downregulation of insulin-like growth factor binding protein 1a (igfbp1a) in osteoblasts ( Figure 8A) . Interestingly, insulin-like growth factor 1 signaling is dysregulated in single-suture craniosynostosis and control ECM focal adhesion and the human homolog igfbp1a is known to be expressed in osteoblastic cells, and to inhibit collagen gene expression by blocking the effect of insulin growth factor 1 (Stamper et al., 2011; Rosen et al., 1994) .
Our analysis of the DEGs confirmed our starting hypothesis, i.e. that fgfr3 loss of function perturbed the differentiation of both late osteoprogenitors and immature osteoblasts. These defects are associated with marked modifications of the ECM and abnormal mineralization, as evidenced by Alizarin red S staining. Impairment of late osteoprogenitor differentiation and ECM synthesis might explain the defect in immature expansion observed in fgfr3 lof1/lof1 zebrafish.
Discussion
By leveraging our new zebrafish fgfr3 lof/lof mutant, we assessed the involvement of Fgfr3 in cranial vault development and membranous ossification. fgfr3 loss of function induced marked anomalies in the craniofacial skeleton, with microcephaly, Wormian bone formation, and small frontal and parietal bones. As Fgfr3 knock-out mice do not present obvious craniofacial anomalies, the fgfr3 lof/lof zebrafish appears to be the first animal model to display much the same craniofacial defects (microcephaly and Wormian bones) as in human FGFR3 loss-of-function related diseases (Deng et al., 1996; Eswarakumar and Schlessinger, 2007; Makrythanasis et al., 2014; Toydemir et al., 2006) .
The different craniofacial phenotypes observed in humans, zebrafish and mice with FGFR3 loss-of-function mutations might be due to interspecies differences in the fgfr3 gene's expression profile. In humans, FGFR3 is expressed during cranial vault formation and suture formation. On the fertile side of the sutures, FGFR3 is expressed less strongly than FGFR2 and FGFR1 (Delezoide et al., 1998) . In the zebrafish, previous studies and our present single-cell transcriptomic analysis revealed that expression levels of fgfr3 are higher than those of fgfr1a, fgfr1b and fgfr2 in (i) late osteoprogenitors and osteoblasts during cranial vault development and (ii) the osteogenic cells lining the suture's mineralization front (Topczewska et al., 2016) . The situation is different in the rodent; Fgfr3c is almost completely absent from developing cranial bones, and is more weakly expressed than Fgfr2c and Fgfr1c in osteogenic fronts and sutures (Molténi et al., 1999; Rice et al., 2003) . Fgfr2 and Fgfr1 are known to be regulators of cranial bone formation, whereas Fgfr3's role is not well understood (Ornitz and Marie, 2019) . Earlier studies evidenced the upregulation of Fgfr1c and Fgfr2c expression in osteoblastic cells isolated from murine Fgfr3 -/bone marrow stromal cells (Valverde-Franco et al., 2004) . These data indicate that Fgfr1c and Fgfr2c can compensate for the absence of Fgfr3c during cranial vault formation in the mouse.
In our single-cell analyses, expression levels of fgfr1a, fgfr1b and fgfr2 were similar in fgfr3 lof1/lof1 zebrafish and controls. These findings demonstrated that the absence of fgfr3 was not compensated for in fgfr3 lo1/lof1 fish.
Cranial vault formation starts with the formation of ossification centers via the condensation of mesenchymal cells and the latter's differentiation into osteoprogenitors, immature osteoblasts and then mature osteoblasts. Bone growth combines the production of osteoids, their mineralization by osteoblasts, and the continued differentiation of mesenchymal cells at the periphery. The role of Fgfr3 during osteoblast differentiation is subject to debate; a recent review suggested that Fgfr3 (i) indirectly regulates osteoblasts during cranial vault development, and (ii) has paracrine properties in the context of endochondral ossification (Ornitz and Marie, 2019; Matsushita et al., 2009; Mugniery et al., 2012; Wen et al., 2016) . Other in vitro studies have demonstrated a direct effect of fgfr3 on osteoblast differentiation (Su et al., 2010; Valverde-Franco et al., 2004) . Nevertheless, the absence of Fgfr3 and the expression of a constitutively activated form of Fgfr3 in mouse cells lead to premature osteoblast differentiation and impairment of the mineralization process. Here, we took advantage of the zebrafish model to perform live in vivo imaging. We found that Fgfr3 regulates the expansion and differentiation of immature osteoblasts during membranous ossification. Our results evidenced high expression levels of fgfr3 in osteoblasts and (to a lesser extent) late osteoprogenitor cells -indicating that Fgfr3 acts directly on osteogenesis in the zebrafish.
The key features of cranial vault bone formation include the relative locations of ossification centers of the individual vault bones. In our study, we observed that the 15 primary ossification center in both mutant and control was indeed initiated in the early stages of development. We showed that the impairment of ossification center expansion is consistent with the increase in cell cycle duration observed in mutant immature osteoblasts at 9SL, and leads to a decrease over time in the immature osteoblast count. One can reasonably assume that this defect in immature osteoblast expansion results from a defect of new osteoblast recruitment, which depends on the osteoprogenitor population. It is important to note that the maturation of osteoblasts from 9SL to 11SL was also blocked, as revealed by the presence of a huge number of immature osteoblasts. The impairment of each step in osteogenesis only appeared once ossification growth had been initiated -suggesting that the cells' position with regard to the ossification center is crucial, and that cell-cell communication was defective. Consistently, our differential gene expression analysis revealed that the absence of functional Fgfr3 is associated with changes in the production of ECM constituents by osteoblasts and osteoprogenitors. The ECM proteins have an important role in cell-cell communication, including matrix bridge formation and morphogen regulation. It has been well established that the osteoblasts in the ossification center secrete morphogens that diffuse into neighboring cells and activate mesenchymal cell differentiation (Garzón-Alvarado et al., 2013; Lee et al., 2015) . Here, the DEGs included fmod and aspn, both of which code for small leucine-reach repeat proteoglycans (fibromodulin and asporin, respectively) expressed in the ECM of bone, cartilage and tendons. It is known that in osteoarthritic cartilage, fibromodulin and asporin are able to modulate TGF-beta signaling by sequestrating TGFb1 within the ECM (Embree et al., 2010; Kalamajski et al., 2009) . Fmod also controls the fate of tendon progenitor cells by modulating bone morphogenic protein activities (Bi et al., 2007) . In the present context, we hypothesized that dysregulation of fmod and aspn impaired the shaping of the morphogenetic fields required for proper bone development. Moreover, we observed the upregulation of col6a1, col12a1a and col12a1b; these collagen gene products are known to be involved in the formation of matrix bridges between cells during osteogenesis, and are essential for proper bone formation (Izu et al., 2016 (Izu et al., , 2011 . On the basis of these data, we assume that the changes in ECM components in growing bone caused by the absence of fgfr3 impair cell-cell communication and thus disturb the recruitment of new osteoblasts. Further in-depth analysis of the ECM and signaling pathways in fgfr3 lof/lof fish will be necessary to confirm our hypothesis.
Interestingly, the absence of Fgfr3 in zebrafish (as in humans) leads to Wormian bone formation (Toydemir et al., 2006) . In humans, these bones are found in the general population but are primarily associated with several genetic bone disorders involving skull deformation (hydrocephaly, craniosynostosis, cleidocranial dysplasia, osteogenesis imperfecta, etc.) (Bellary et al., 2013; Sanchez-Lara et al., 2007) . Our observations revealed that in contrast to the zebrafish sp7 knock-out model showing that Wormian bone formation resulted from the increase in early osteoblast recruitment, in fgfr3 lof/lof fish the ectopic bones appeared as a result of the bone formation delay (Kague et al., 2016) . Our data highlighted the complexity of Wormian bone formation, a topic that warrants further investigation.
In conclusion, the fgfr3 lof1/lof1 zebrafish is the first animal model to have enabled an in vivo analysis of Fgfr3's role in intramembranous ossification. Thanks to the late development and accessibility of the cranial vault, the fgfr3 lof1/lof1 model provides unprecedented access to the mechanism of bone formation in a live animal. Moreover, the phenotype displayed by the mutant fish is closer to that seen in humans than that observed in the mouse (e.g. the presence of Wormian bones and microcephaly). Our We expect these data to be of value in understanding skull vault anomalies observed in patients with FGFR3-related disorders.
Materials and Methods
Zebrafish husbandry and transgenic strains.
Zebrafish were raised, hatched and maintained in an animal house at 28°C (approval number 2018080216094268), in compliance with the EU Directive 2010/63/EU for animals. Fish were studied at various developmental stages, and the standard length (SL) was measured from the snout to the caudal peduncle (Parichy et al., 2009) . The Tg(sp7:mCherry) and Tg(bglap:GFP) fish lines have been previously described; they labeled immature osteoblasts and mature osteoblasts, respectively (Knopf et al., 2011) . The Tg(col2:mCherry) fish line was used to label chondrocytes (Hammond and Schulte-Merker, 2009 ).
BGJ398 treatment.
Tg: (sp7: mCherry) zebrafish with an SL of 7mm at treatment initiation received intraperitoneal administrations of BGJ398 (2 mg/kg body weight) (infigratinib; LC Laboratories) or vehicle (3.5 mM HCl, DMSO 3%) every other day for 15 days. After treatment, fish were euthanized by balneation in 75 µg/L benzocaine solution.
Photographs were taken with an M2015FCA stereomicroscope equipped with a Leica DFC300G camera and a filter for mCherry. The SL and fontanelle area were measured using Fiji software (Schindelin et al., 2012) .
Generation of the CRISPR/Cas9 Fgfr3 lof zebrafish line
Two loss-of-function fgfr3 lines were established by using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) genome editing. Single guide RNAs were designed using the CRISPOR online tool (http://crispor.tefor.net).
The fgfr3 targets in this study were 5′-TTTGTGCTCTCTGTGTCAGCGG-3′ and 5′-GCCCACCACTACCGTCTGAT-3' for the fgfr3 lof1 and fgfr3 lof2 lines, respectively. 278. We crossed fgfr3 +/lof females and fgfr3 +flof females to obtain fgfr3 lof/lof , and fgfr3 +f+ siblings as controls for phenotypic analyses.
Genotyping.
Genomic DNA was isolated from caudal fin biopsies. Tissues were lysed in 10mM Tris-HCl, pH 8.5, 2mM EDTA pH8, 0.2% Triton X-100 and 250 µg/ml proteinase K (Sigma Aldrich) for at least 1h at 55°C. The samples were genotyped in heteroduplex mobility assay using the following primers fgfr3 lof1 _F: 5'-TGAACGATCCCAGGAATCCC-3' and fgfr3 lof1 _R: 5'-GGTGAGAATGAAGAGCACGC-3', fgfr3 lof2 _F: 5'-CAACTCGATGTGCTGGGTAT-3' and fgfr3 lof2 _R: 5'-GCTGAGCATCACTGTACACC-3'.
Skeletal staining
Alizarin red S staining of 9dpf larvae: Bones were stained with Alizarin red S (Sigma Aldrich), using the method described by Walker and Kimmel (Walker and Kimmel, 2007 Vital staining with calcein green and Alizarin red: Zebrafish at 9 SL were used for live staining. Using water from the fish facility, 0.003% Alizarin red S and 0.005% calcein green (Sigma Aldrich) stains were applied sequentially in overnight incubations. The Alizarin red S stain was applied at 9SL, and was followed by calcein green staining 7 days later.
The fish were imaged with an M2015FCA stereomicroscope equipped with both a Leica DFC300G camera (a mCherry filter was used to image Alizarin Red, and a GFP filter was used to image calcein) and a Leica MC 170HD camera for bright-field images.
X-ray and µCT analyses
The fish's whole skeletons were X-rayed using a Faxitron (MX-20DC12). Vertebrae were measured on the radiographs, using Image J software. Micro computed tomography (voxel size: 2 μm) on a Skyscan 1272 system (Bruker)) was used to evaluate the skull morphology in fgfr3 lof1/lof1 and fgfr3 +/+ fish (n=5 per group). The skull of each fish was dissected, fixed in 4% phosphate-buffered formaldehyde for at least 24 hours, dried in a series of increasingly concentrated ethanol solutions and, lastly, dried in air. To reduce movement, specimens were glued to a sample holder during the µCT scan. Scans were acquired at 40 kV and 240 μA with a 0.25 mm aluminum filter. Ring artifacts and beam hardening corrections were the same for all scans, during reconstruction with NRecon software (Bruker) according to previously established protocols (Busse et al., 2019; Fiedler et al., 2018; Suniaga et al., 2018) .
Histological analyses and in situ hybridization.
Whole fish were fixed overnight in 4% paraformaldehyde at 4°C, decalcified in a 0.5 M EDTA pH 8.0 solution for 3 weeks, and embedded in paraffin. Serial sections of 6 mm were stained with hematoxylin-eosin or underwent an in situ hybridization analysis. 
Immunohistochemistry and EdU Labeling
For 5-ethynyl-2′-deoxyuridine (EdU) incorporation experiments, 9SL fish were intraperitoneally injected with 1 µl of 10 mM EdU solution per 15 mg using a microinjector. One hour later, the fish were then killed by over-anesthesia. Next, the calvaria were dissected out and processed as described below for immunohistochemical assessment. EdU was detected with the EdU Click-iT Plus EdU
Alexa Fluor 488 Imaging Kit (Life Technologies), according to the manufacturer's instructions.
For the immunohistochemical assessment, dissected calvaria from 9SL or 11SL fish were labeled with antibodies against mCherry (Takara, 1/100), GFP (Roche, 1/100) and pH3 (Abcam; 1/100). The calvaria were fixed in 4% paraformaldehyde (Electron 1.2) . The mCherry-positive volume was used to extract the volumes of interest for analysis.
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Sequential imaging
For sequential live imaging, fish were anesthetized with benzocaine (75 µg/L) and mounted in a Petri dish in which a well had been carved out of 1% low-melting-point agarose. Sequential pictures were taken in the same orientation, using a Yokogawa CSU-X1 spinning disk scanner coupled to a Zeiss Observer Z1 inverted microscope and a DP72 camera controlled by Zen Blue software (Olympus).
Quantitative real-time PCR
Total RNA from 6-week-old fish was extracted with Trizol reagent (Thermo Fisher and R 5'-CACTGGGATACCTGGATACG -3'). In the qPCR, expression of fgfr1a, fgfr1b, fgfr2, and fgfr3 were normalized against actin, gene expression was quantified using the equation 2 −ΔΔCT , and the fold-change in mRNA expression was calculated relative to the mRNA level in one of the controls (set to 1).
Cell dissociation, fluorescence-activated cell sorting, single-cell sample preparation, and RNA sequencing
The cranial vault was isolated from the head of 9SL zebrafish and dissected in PBS.
The olfactory bulbs, the anterior parts of the frontal bones, and the suboccipital bones were removed (Figure 6 A) . The soft tissue was partially degraded by incubation with 0.2% collagenase (Sigma-Aldrich-C5138) and 4 mM EDTA in PBS (Gibco) for 10 min at 28°C. After a wash in PBS, cells were dissociated for 40 min at 28°C in 0.2% collagenase in PBS. The solution was strained using a 40 μm cell strainer (Corning), and the cells were washed in -MEM supplemented with 10% FBS. Prior to flow cytometry, the cells were suspended in FacsMax (amsbio) and stained with Sytox TM green nucleic acid stain (1:100000, Invitrogen) and Hoechst (1:5000, Thermo Fisher).
To sort the cells, beads (Sony-LE-B3001) were used to select events larger than 3 µm.
Hoechst-positive cells (cells with a nucleus) and Syber-green-negative cells (live cells)
were sorted on an Aria 2 sorp cell sorter (Beckson Dickinson).
The scRNA-seq libraries were generated with a Chromium Single Cell 3′ Fastq files from the scRNA 10X libraries were processed using the CellRanger Count pipeline with its default parameters. Reads were aligned against the GRCz11-3.0.0 reference transcriptome. The RNA data quality control and downstream analysis were performed using the Seurat R package (version 3.0.2) and the standard Seurat v3 integration workflow (Stuart et al., 2019) . We filtered cells that had (i) unique feature counts over 2000 or below 500, or (ii) more than 20% of mitochondrial counts. After data filtering, we obtained an expression matrix with 21176 genes and 19245 cells.
The matrix's dimensions were reduced by running the 20 significant principal components against scaled data. To identify cell populations, we started with a clustering resolution of 0.6, used the expression of a panel of gene markers to annotate clusters, and then decreased the resolution to 0.2 to refine the clusters. 
Pseudotime analysis
The top 1000 highly dispersed genes among the osteogenic lineage cell clusters (OP0, OP1, OP2, OP3, OP4, OP5, OB) in WT fish were chosen as feature genes to resolve pseudotemporal trajectories using the setOrderingFilter, reduceDimension, and orderCells functions of Monocle (v2.8.0). We used the default parameters (except for max_components = 4 and norm_method = log) to generate the 3D trajectory during dimensionality reduction.
Statistical analysis
All statistical analyses were performed using Prism 6 (GraphPad Software), with the statistical tests and corresponding two-tailed P-values reported in the figure legends: *, p<0.05, **, p<0.01, ***, p<0.001 and ****, p<0.0001 were considered to be statistically significant. All values are quoted as the mean +SEM. 
